Modulation of FGF pathway signaling and vascular differentiation using designed oligomeric assemblies.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 38861993.
- Also identified by DOI 10.1016/j.cell.2024.05.025 and PMC identifier 11246234.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Many growth factors and cytokines signal by binding to the extracellular domains of their receptors and driving association and transphosphorylation of the receptor intracellular tyrosine kinase domains, initiating downstream signaling cascades. To enable systematic exploration of how receptor valency and geometry affect signaling outcomes, we designed cyclic homo-oligomers with up to 8 subunits using repeat protein building blocks that can be modularly extended. By incorporating a de novo-designed fibroblast growth factor receptor (FGFR)-binding module into these scaffolds, we generated a series of synthetic signaling ligands that exhibit potent valency- and geometry-dependent Ca<sup>2+</sup> release and mitogen-activated protein kinase (MAPK) pathway activation. The high specificity of the designed agonists reveals distinct roles for two FGFR splice variants in driving arterial endothelium and perivascular cell fates during early vascular development. Our designed modular assemblies should be broadly useful for unraveling the complexities of signaling in key developmental transitions and for developing future therapeutic applications.
Medical subject headings
- Receptors, Fibroblast Growth Factor
- Signal Transduction
- Fibroblast Growth Factors
- Cell Differentiation